Advertisement
UK markets closed

  • FTSE 100

    8,039.29
    -5.52 (-0.07%)
     

  • FTSE 250

    19,705.54
    -94.18 (-0.48%)
     

  • AIM

    753.96
    -0.91 (-0.12%)
     

  • GBP/EUR

    1.1633
    +0.0005 (+0.04%)
     

  • GBP/USD

    1.2434
    -0.0019 (-0.15%)
     

  • Bitcoin GBP

    52,163.45
    -1,552.18 (-2.89%)
     

  • CMC Crypto 200

    1,406.35
    -17.75 (-1.25%)
     

  • S&P 500

    5,063.37
    -7.18 (-0.14%)
     

  • DOW

    38,372.81
    -130.88 (-0.34%)
     

  • CRUDE OIL

    82.91
    -0.45 (-0.54%)
     

  • GOLD FUTURES

    2,344.90
    +2.80 (+0.12%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,064.91
    -72.74 (-0.40%)
     

  • CAC 40

    8,085.11
    -20.67 (-0.26%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023

Alex Carchidi, The Motley Fool
·5-min read
Get Ready to Soar: 2 High-Octane Growth Stocks Wall Street Expects to Climb in 2023

Wall Street analysts aren't always right with their predictions about stocks, but they typically have a strong argument for why they think a given outcome is going to happen. On that note, let's evaluate a couple of growth stocks that Wall Street has high hopes for to see if they might be a good fit for your portfolio. When it comes to businesses making medical aesthetics treatments that are alternatives to plastic surgeries and face lifts, InMode (NASDAQ: INMD) is a leader.

Continue reading